Actively Recruiting
Validation of a Rapid Screening Tool for Anxiety-depressive Disorders in Children, Adolescents and Young Adults Treated in Oncology. Multicenter Study.
Led by Centre Hospitalier Universitaire de Saint Etienne · Updated on 2026-03-30
545
Participants Needed
7
Research Sites
128 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In France today, it is estimated that one in every 850 people aged between 20 and 45 is a childhood cancer survivor (CCS), equivalent to around 40,000 to 50,000 people. Some descriptive studies have established that the diagnosis and treatment of cancer can affect psychological health. A French study published by our team in 2015 and 2020 showed that in adulthood, 40% of CCS had anxiety symptoms, a rate significantly higher than that of the general French population (25%). However, although there are validated scales for screening children for psychological disorders (anxiety, depression, etc.), there is no rapid screening tool that can be used routinely by an oncologist during consultations. So, the study aims to develop and validate a short test, which could easily be carried out systematically during follow-up consultations after childhood cancer. It would make it possible to identify people with no psychological complications and, conversely, those in whom further investigation, based on the classic reference scales for assessing psychological disorders, would be relevant.
CONDITIONS
Official Title
Validation of a Rapid Screening Tool for Anxiety-depressive Disorders in Children, Adolescents and Young Adults Treated in Oncology. Multicenter Study.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with pediatric cancer before the age of 18
- Intensive treatment ended at least 3 months prior to inclusion
- Patients considered to be in complete remission by their treating doctor
- Patient is affiliated with or entitled to a social security scheme
- Patient or legal guardian has received informed information about the study
You will not qualify if you...
- Refusal to participate by the patient or minor
- Patients with cancer that has relapsed or progressed
- Pregnant women, women in labor, or breastfeeding mothers
- Persons deprived of liberty, hospitalized without consent, or hospitalized for reasons other than the research
- Adults under legal protection (guardianship) or unable to give consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 7 locations
1
Centre Hospitalier Universitaire Caen Normandie
Caen, France, 14033
Not Yet Recruiting
2
Centre Hospitalier Universitaire
Grenoble, France, 38043
Not Yet Recruiting
3
IHOP
Lyon, France, 69000
Actively Recruiting
4
CENTRE HOSPITALIER UNIVERSAIRE DE NICE - Hôpital Archet 2
Nice, France, 06200
Not Yet Recruiting
5
Centre Hospitalier Universitaire
Rouen, France, 76000
Not Yet Recruiting
6
CHU de Saint-Etienne
Saint-Etienne, France, 42000
Actively Recruiting
7
Hopitaux Universitaires de Strasbourg, Hopital Hautepierre
Strasbourg, France, 67200
Not Yet Recruiting
Research Team
C
CLAIRE BERGER, MD
CONTACT
L
Léonie CASAGRANDA, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here